AFCG vs GSK · rev $15.6M vs P/E 13, $103.31B cap
AFC Gamma Inc (AFCG) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
AFC Gamma Inc (AFCG) is a asset management company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AFCG revenue for 2026-06-30 was $15.6M. Net income was $16.8M. AFCG currently screens at market cap $77.2M.
GSK does not have a complete income-statement cache yet.
AFCG currently screens at market cap $77.2M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AFCG and GSK stock pages for the full models.
Not investment advice.